Show simple item record

dc.contributor.authorAzizlerli, H
dc.contributor.authorYarman, S
dc.contributor.authorTanakol, R
dc.contributor.authorOguz, H
dc.contributor.authorAlagol, F
dc.contributor.authorSandalci, O
dc.date.accessioned2021-03-05T11:07:09Z
dc.date.available2021-03-05T11:07:09Z
dc.date.issued1997
dc.identifier.citationYarman S., Sandalci O., Tanakol R., Azizlerli H., Oguz H., Alagol F., "Prophylthiouracil-induced cutaneous vasculitis", INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, cilt.35, ss.282-286, 1997
dc.identifier.issn0946-1965
dc.identifier.othervv_1032021
dc.identifier.otherav_a695f0fc-757d-4556-bf5d-8b5a549d0ebe
dc.identifier.urihttp://hdl.handle.net/20.500.12627/111402
dc.identifier.urihttps://doi.org/10.1111/j.1398-9995.1997.tb02607.x
dc.description.abstractCutaneous reactions to propylthiouracil and methimazole occur in 3% - 5% of adults. Generalized maculopapular and papular purpuric eruptions are perhaps the most common thionamide-induced reactions. We report 3 patients who developed cutaneous vasculitis which is a rare and serious side-effect during antithyroid drug therapy. The observation of cutaneous vasculitis during administration of propylthiouracil suggested that clinical awareness of this complication should be of considerable importance.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleProphylthiouracil-induced cutaneous vasculitis
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
dc.contributor.department, ,
dc.identifier.volume35
dc.identifier.issue7
dc.identifier.startpage282
dc.identifier.endpage286
dc.contributor.firstauthorID119101


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record